Key Papers


Sunday, December 2nd 2012

Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ.

“Personalized PSA Testing Using Genetic Variants May Reduce Unnecessary Biopsies.”

Journal of Urology 2012; epub December. PMID: 23246478.

Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631301/

Correcting the PSA level for a man’s genotype could potentially reduce the number of men referred for prostate biopsy by up to 20%, while reducing the number of potentially delayed diagnoses by 3% for men with genetically lower PSA levels.

Comments are closed.